Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-22-037853

Options or other derivatives

  • Director acquired 41,841 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Greene Rick S. Director 2022-06-15 Grant or award · Stock Option (Right to Buy) +41,841 41,841 D: show line 1 in the form
Loading xslF345X03/doc4.xml…